|
1
|
Veeranna V, Zalawadiya SK, Nirai A,
Pradhan J, Ference B, Burack RC, Jacob S and Afonso L: Homocysteine
and reclassification of cardiovascular disease risk. J Am Coll
Cardiol. 58:1025–1033. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mayer EL, Jacobsen DW and Robinson K:
Homocysteine and coronary atherosclerosis. J Am Coll Cardiol.
27:517–527. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schaffer A, Verdoia M, Cassetti E, Marino
P, Suryapranata H and De Luca G: Novara Atherosclerosis Study Group
(NAS): Relationship between homocysteine and coronary artery
disease. Results from a large prospective cohort study. Thromb Res.
134:288–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anderson JL, Muhlestein JB, Horne BD,
Carlquist JF, Bair TL, Madsen TE and Pearson RR: Plasma
homocysteine predicts mortality independently of traditional risk
factors and C-reactive protein in patients with angiographically
defined coronary artery disease. Circulation. 102:1227–1232. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun Q, Jia X, Gao J, Mou W, Tong H, Wen X
and Tian Y: Association of serum homocysteine levels with the
severity and calcification of coronary atherosclerotic plaques
detected by coronary CT angiography. Int Angiol. 33:316–323.
2014.PubMed/NCBI
|
|
6
|
Shenoy V, Mehendale V, Prabhu K, Shetty R
and Rao P: Correlation of serum homocysteine levels with the
severity of coronary artery disease. Indian J Clin Biochem.
29:339–344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mirhosseini SJ, Forouzannia SK,
Mirhosseini SA, Ali-Hassan-Sayegh S and Mozayan MR: Intra-operative
grading of coronary artery atherosclerosis associated with
homocysteine levels in postmenopausal women undergoing elective
off-pump CABG surgery. Niger Med J. 53:192–195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parthasarathy S: Oxidation of low-density
lipoprotein by thiol compounds leads to its recognition by the
acetyl LDL receptor. Biochim Biophys Acta. 917:337–340. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zou T, Yang W, Hou Z and Yang J:
Homocysteine enhances cell proliferation in vascular smooth muscle
cells: Role of p38 MAPK and p47phox. Acta Biochim Biophys Sin
(Shanghai). 42:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shirpoor A, Salami S, Ansari Khadem MH,
Ilkhanizadeh B and Abdollahzadeh N: Ethanol promotes rat aortic
vascular smooth muscle cell proliferation via increase of
homocysteine and oxidized low-density lipoprotein. J Cardiol.
62:374–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Woo KS, Chook P, Lolin YI, Cheung AS, Chan
LT, Sun YY, Sanderson JE, Metreweli C and Celermajer DS:
Hyperhomocyst(e)inemia is a risk factor for arterial endothelial
dysfunction in humans. Circulation. 96:2542–2544. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Snehalatha C, Ramachandran A, Satyavani K,
Sivasankari S, Sathyamurthy I and Viswanathan V: Plasma
homocysteine concentration and coronary artery disease in Asian
Indians. J Assoc Physicians India. 50:1229–1231. 2002.PubMed/NCBI
|
|
13
|
Boufidou AI, Makedou AD, Adamidis DN,
Karvounis HI, Gourassas JT, Kesidis HT, Makedou KG, Papadopoulos
CE, Parharidis GE and Louridas GE: Association between plasma
homocysteine levels and coronary artery disease: A population-based
study in northern Greece. Curr Med Res Opin. 20:175–180. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaul S, Zadeh AA and Shah PK: Homocysteine
hypothesis for atherothrombotic cardiovascular disease: Not
validated. J Am Coll Cardiol. 48:914–923. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumar KG, Trevaskis JL, Lam DD, Sutton GM,
Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA,
Thearle M, et al: Identification of adropin as a secreted factor
linking dietary macronutrient intake with energy homeostasis and
lipid metabolism. Cell Metab. 8:168–481. 2008. View Article : Google Scholar
|
|
16
|
Lovren F, Pan Y, Quan A, Singh KK, Shukla
PC, Gupta M, Al-Omran M, Teoh H and Verma S: Adropin is a novel
regulator of endothelial function. Circulation. 122(Suppl 1):
S185–S192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumar Ganesh K, Zhang J, Gao S, Rossi J,
McGuinness OP, Halem HH, Culler MD, Mynatt RL and Butler AA:
Adropin deficiency is associated with increased adiposity and
insulin resistance. Obesity (Silver Spring). 20:1394–1402. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu HY, Zhao P, Wu MC, Liu J and Yin W:
Serum adropin levels are decreased in patients with acute
myocardial infarction. Regul Pept 190–191. 46–49. 2014. View Article : Google Scholar
|
|
19
|
Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C
and Fan L: Low serum adropin is associated with coronary
atherosclerosis in type 2 diabetic and non-diabetic patients. Clin
Chem Lab Med. 52:751–758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rabe-Hesketh S, Skorndal A and Pickles A:
Generalized multilevel structural equation modeling. Psychometrika.
69:167–190. 2004. View Article : Google Scholar
|
|
21
|
El Oudi M, Bouguerra C, Aouni Z, Mazigh C,
Bellaaj R and Machghoul S: Homocysteine and inflammatory biomarkers
plasma levels and severity of acute coronary syndrome. Ann Biol
Clin (Paris). 69:175–180. 2011.PubMed/NCBI
|
|
22
|
Wu Y, Yang L and Zhong L: Decreased serum
levels of thioredoxin in patients with coronary artery disease plus
hyperhomocysteinemia is strongly associated with the disease
severity. Atherosclerosis. 212:351–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bertoia ML, Pai JK, Cooke JP, Joosten MM,
Mittleman MA, Rimm EB and Mukamal KJ: Plasma homocysteine, dietary
B vitamins, betaine and choline and risk of peripheral artery
disease. Atherosclerosis. 235:94–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Debreceni B and Debreceni L: The role of
homocysteine-lowering B-vitamins in the primary prevention of
cardiovascular disease. Cardiovasc Ther. 32:130–138. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boushey CJ, Beresford SA, Omenn GS and
Motulsky AG: A quantitative assessment of plasma homocysteine as a
risk factor for vascular disease. Probable benefits of increasing
folic acid intakes. JAMA. 274:1049–1057. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ungvari Z, Csiszar A, Edwards JG, Kaminski
PM, Wolin MS, Kaley G and Koller A: Increased superoxide production
in coronary arteries in hyperhomocysteinemia: Role of tumor
necrosis factor-alpha, NAD(P)H oxidase and inducible nitric oxide
synthase. Arterioscler Thromb Vasc Biol. 23:418–424. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Au-Yeung KK, Woo CW, Sung FL, Yip JC and
Siow YLOK: Hyperhomocysteinemia activates nuclear factor-kappaB in
endothelial cells via oxidative stress. Circ Res. 94:28–36. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shirodaria C, Antoniades C, Lee J, Jackson
CE, Robson MD, Francis JM, Moat SJ, Ratnatunga C, Pillai R, Refsum
H, et al: Global improvement of vascular function and redox state
with low-dose folic acid: Implications for folate therapy in
patients with coronary artery disease. Circulation. 115:2262–2270.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cacciapuoti F: Lowering homocysteine
levels with folic acid and B-vitamins do not reduce early
atherosclerosis, but could interfere with cognitive decline and
Alzheimer's disease. J Thromb Thrombolysis. 36:258–262. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bønaa KH, Njølstad I, Ueland PM, Schirmer
H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E and
Rasmussen K: NORVIT Trial Investigators: Homocysteine lowering and
cardiovascular events after acute myocardial infarction. N Engl J
Med. 354:1578–1588. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lonn E, Yusuf S, Arnold MJ, Sheridan P,
Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, et
al: Homocysteine lowering with folic acid and B vitamins in
vascular disease. N Engl J Med. 354:1567–1577. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Celik A, Balin M, Kobat MA, Erdem K,
Baydas A, Bulut M, Altas Y and Aydin S and Aydin S: Deficiency of a
new protein associated with cardiac syndrome X; called adropin.
Cardiovasc Ther. 31:174–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Topuz M, Celik A, Aslantas T, Demir AK and
Aydin S and Aydin S: Plasma adropin levels predict endothelial
dysfunction like flow-mediated dilatation in patients with type 2
diabetes mellitus. J Investig Med. 61:1161–1164. 2013.PubMed/NCBI
|
|
34
|
Sanchez-Margalet V, Valle M, Ruz FJ,
Gascon F, Mateo J and Goberna R: Elevated plasma total homocysteine
levels in hyperinsulinemic obese subjects. J Nutr Biochem.
13:75–79. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martos R, Valle M, Morales R, Cañete R,
Gavilan MI and Sánchez-Margalet V: Hyperhomocysteinemia correlates
with insulin resistance and low-grade systemic inflammation in
obese prepubertal children. Metabolism. 55:72–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pravenec M, Kozich V, Krijt J, Sokolová J,
Zídek V, Landa V, Simáková M, Mlejnek P, Silhavy J, Oliyarnyk O, et
al: Folate deficiency is associated with oxidative stress,
increased blood pressure and insulin resistance in spontaneously
hypertensive rats. Am J Hypertens. 26:135–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Najib S and Sánchez-Margalet V:
Homocysteine thiolactone inhibits insulin signaling and glutathione
has a protective effect. J Mol Endocrinol. 27:85–91. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng
J, Xiang X, Kong W, Xu G, Li Y and Wang X: Hyperhomocysteinemia
promotes insulin resistance by inducing endoplasmic reticulum
stress in adipose tissue. J Biol Chem. 288:9583–9592. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chua S, Wu CJ, Chang HW, Hang CL, Chen CJ,
Yang CH and Yip HK: Impact of elevated plasma total homocysteine
concentration on coronary atherosclerosis in Chinese patients with
acute myocardial infarction undergoing primary coronary
intervention. Int Heart J. 46:181–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Sim AS, Wang XL, Salonikas C,
Moriatis M, Naidoo D and Wilcken DE: Relations between markers of
renal function, coronary risk factors and the occurrence and
severity of coronary artery disease. Atherosclerosis. 197:853–859.
2008. View Article : Google Scholar : PubMed/NCBI
|
